HK Stock MarketDetailed Quotes

CRCCE (01786)

Watchlist
  • 0.830
  • +0.010+1.22%
Not Open Apr 24 16:05 CST
1.26BMarket Cap7.90P/E (TTM)

CRCCE (01786) Income Statement

All
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q6)Jun 30, 2025
(FY)Dec 31, 2024
(Q6)Jun 30, 2024
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(Q6)Jun 30, 2021
Turnover
10.17%3.44B
0.55%1.73B
0.63%3.12B
7.43%1.72B
9.85%3.1B
30.09%1.6B
29.09%2.82B
23.82%1.23B
40.30%2.19B
119.51%995.39M
Operating income
10.17%3.44B
0.55%1.73B
0.63%3.12B
7.43%1.72B
9.85%3.1B
30.09%1.6B
29.09%2.82B
23.82%1.23B
40.30%2.19B
119.51%995.39M
Operating expenses
-12.44%-2.84B
-1.66%-1.45B
5.64%-2.52B
-8.22%-1.43B
-23.88%-2.67B
-42.57%-1.32B
-31.55%-2.16B
-24.09%-925.77M
-47.64%-1.64B
-146.93%-746.06M
Gross profit
0.56%599.52M
-4.86%279.74M
40.00%596.16M
3.74%294.04M
-35.80%425.82M
-7.60%283.44M
21.70%663.25M
23.03%306.76M
22.03%545M
64.76%249.33M
Selling expenses
7.91%-109.79M
-16.47%-62.82M
8.58%-119.22M
31.39%-53.94M
-0.62%-130.41M
-32.58%-78.62M
-15.10%-129.6M
0.38%-59.3M
-16.95%-112.6M
-111.82%-59.53M
Administrative expenses
19.49%-137.69M
21.42%-61.33M
0.72%-171.02M
0.09%-78.05M
7.65%-172.26M
6.03%-78.12M
-4.26%-186.52M
2.35%-83.14M
-7.99%-178.9M
-4.41%-85.14M
Research and development expenses
10.83%-212.18M
38.22%-82.22M
33.71%-237.95M
-9.60%-133.08M
-37.50%-358.95M
15.37%-121.43M
-44.91%-261.05M
-67.68%-143.48M
-22.05%-180.15M
-34.58%-85.57M
Profit from asset sales
128.90%75.89K
-271.64%-305.47K
-100.05%-262.59K
85.22%-82.19K
196,750.89%500.85M
-299.62%-556.19K
-38.69%254.43K
1,544.86%278.62K
554.84%414.98K
-452.76%-19.28K
Impairment and provision
-189.48%-13.29M
-359.32%-19.15M
111.17%14.86M
-112.72%-4.17M
-2,446.46%-133.02M
626.11%32.77M
109.26%5.67M
40.35%-6.23M
-43.88%-61.19M
45.16%-10.44M
-Other impairment is provision
-189.48%-13.29M
-359.32%-19.15M
111.17%14.86M
-112.72%-4.17M
-2,446.46%-133.02M
626.11%32.77M
109.26%5.67M
40.35%-6.23M
-43.88%-61.19M
45.16%-10.44M
Special items of operating profit
-32.56%34.75M
-49.42%16.56M
301.55%51.53M
268.84%32.74M
-60.31%12.83M
-51.91%8.88M
19.98%32.33M
71.93%18.46M
219.80%26.95M
67.04%10.74M
Operating profit
26.53%135.35M
20.03%61.06M
-11.45%106.97M
36.17%50.87M
14.81%120.8M
57.59%37.36M
433.43%105.21M
157.48%23.7M
244.56%19.72M
121.85%9.21M
Financing income
1.19%21.77M
-10.70%9.95M
6.03%21.52M
19.38%11.14M
-8.58%20.3M
-1.65%9.33M
-42.60%22.2M
-47.53%9.49M
7.43%38.68M
51.79%18.08M
Financing cost
26.30%-386.27K
9.84%-240.2K
22.08%-524.1K
31.67%-266.42K
---672.58K
---389.92K
----
----
----
----
Special items of earning before tax
-52.63%1.16M
226.87%836.54K
19.37%2.45M
-80.10%255.92K
111.85%2.05M
2,037.15%1.29M
-1,667.12%-17.33M
102.44%60.17K
-109.02%-980.76K
-332.06%-2.47M
Earning before tax
7.36%150.85M
12.61%68.9M
2.50%140.51M
25.26%61.18M
10.85%137.09M
14.05%48.84M
177.62%123.67M
125.07%42.82M
101.22%44.54M
159.32%19.03M
After-tax profit from continuing operations
11.81%144.07M
8.77%66.75M
-11.23%128.85M
36.18%61.37M
25.48%145.14M
8.08%45.07M
129.62%115.67M
111.08%41.7M
127.36%50.38M
175.55%19.75M
Earning after tax
11.81%144.07M
8.77%66.75M
-11.23%128.85M
36.18%61.37M
25.48%145.14M
8.08%45.07M
129.62%115.67M
111.08%41.7M
127.36%50.38M
175.55%19.75M
Minority profit
-72.76%175.21K
19.58%31.53K
503.01%643.31K
-94.43%26.37K
192.74%106.68K
--473.64K
--36.44K
----
----
----
Profit attributable to shareholders
12.24%143.89M
8.76%66.72M
-11.60%128.21M
37.57%61.35M
25.42%145.04M
6.94%44.59M
129.54%115.64M
111.08%41.7M
127.36%50.38M
175.55%19.75M
Basic earnings per share
12.50%0.09
0.00%0.04
-20.00%0.08
33.33%0.04
25.00%0.1
0.00%0.03
166.67%0.08
200.00%0.03
200.00%0.03
150.00%0.01
Diluted earnings per share
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Auditor
PwC China (Special General Partnership)
--
PwC China (Special General Partnership)
--
Lixin Certified Public Accountants (Special General Partnership)
--
Lixin Certified Public Accountants (Special General Partnership)
--
Deloitte Touche Tohmatsu Certified Public Accountants (Special General Partnership)
--
(FY)Dec 31, 2025(Q6)Jun 30, 2025(FY)Dec 31, 2024(Q6)Jun 30, 2024(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(Q6)Jun 30, 2021
Turnover 10.17%3.44B0.55%1.73B0.63%3.12B7.43%1.72B9.85%3.1B30.09%1.6B29.09%2.82B23.82%1.23B40.30%2.19B119.51%995.39M
Operating income 10.17%3.44B0.55%1.73B0.63%3.12B7.43%1.72B9.85%3.1B30.09%1.6B29.09%2.82B23.82%1.23B40.30%2.19B119.51%995.39M
Operating expenses -12.44%-2.84B-1.66%-1.45B5.64%-2.52B-8.22%-1.43B-23.88%-2.67B-42.57%-1.32B-31.55%-2.16B-24.09%-925.77M-47.64%-1.64B-146.93%-746.06M
Gross profit 0.56%599.52M-4.86%279.74M40.00%596.16M3.74%294.04M-35.80%425.82M-7.60%283.44M21.70%663.25M23.03%306.76M22.03%545M64.76%249.33M
Selling expenses 7.91%-109.79M-16.47%-62.82M8.58%-119.22M31.39%-53.94M-0.62%-130.41M-32.58%-78.62M-15.10%-129.6M0.38%-59.3M-16.95%-112.6M-111.82%-59.53M
Administrative expenses 19.49%-137.69M21.42%-61.33M0.72%-171.02M0.09%-78.05M7.65%-172.26M6.03%-78.12M-4.26%-186.52M2.35%-83.14M-7.99%-178.9M-4.41%-85.14M
Research and development expenses 10.83%-212.18M38.22%-82.22M33.71%-237.95M-9.60%-133.08M-37.50%-358.95M15.37%-121.43M-44.91%-261.05M-67.68%-143.48M-22.05%-180.15M-34.58%-85.57M
Profit from asset sales 128.90%75.89K-271.64%-305.47K-100.05%-262.59K85.22%-82.19K196,750.89%500.85M-299.62%-556.19K-38.69%254.43K1,544.86%278.62K554.84%414.98K-452.76%-19.28K
Impairment and provision -189.48%-13.29M-359.32%-19.15M111.17%14.86M-112.72%-4.17M-2,446.46%-133.02M626.11%32.77M109.26%5.67M40.35%-6.23M-43.88%-61.19M45.16%-10.44M
-Other impairment is provision -189.48%-13.29M-359.32%-19.15M111.17%14.86M-112.72%-4.17M-2,446.46%-133.02M626.11%32.77M109.26%5.67M40.35%-6.23M-43.88%-61.19M45.16%-10.44M
Special items of operating profit -32.56%34.75M-49.42%16.56M301.55%51.53M268.84%32.74M-60.31%12.83M-51.91%8.88M19.98%32.33M71.93%18.46M219.80%26.95M67.04%10.74M
Operating profit 26.53%135.35M20.03%61.06M-11.45%106.97M36.17%50.87M14.81%120.8M57.59%37.36M433.43%105.21M157.48%23.7M244.56%19.72M121.85%9.21M
Financing income 1.19%21.77M-10.70%9.95M6.03%21.52M19.38%11.14M-8.58%20.3M-1.65%9.33M-42.60%22.2M-47.53%9.49M7.43%38.68M51.79%18.08M
Financing cost 26.30%-386.27K9.84%-240.2K22.08%-524.1K31.67%-266.42K---672.58K---389.92K----------------
Special items of earning before tax -52.63%1.16M226.87%836.54K19.37%2.45M-80.10%255.92K111.85%2.05M2,037.15%1.29M-1,667.12%-17.33M102.44%60.17K-109.02%-980.76K-332.06%-2.47M
Earning before tax 7.36%150.85M12.61%68.9M2.50%140.51M25.26%61.18M10.85%137.09M14.05%48.84M177.62%123.67M125.07%42.82M101.22%44.54M159.32%19.03M
After-tax profit from continuing operations 11.81%144.07M8.77%66.75M-11.23%128.85M36.18%61.37M25.48%145.14M8.08%45.07M129.62%115.67M111.08%41.7M127.36%50.38M175.55%19.75M
Earning after tax 11.81%144.07M8.77%66.75M-11.23%128.85M36.18%61.37M25.48%145.14M8.08%45.07M129.62%115.67M111.08%41.7M127.36%50.38M175.55%19.75M
Minority profit -72.76%175.21K19.58%31.53K503.01%643.31K-94.43%26.37K192.74%106.68K--473.64K--36.44K------------
Profit attributable to shareholders 12.24%143.89M8.76%66.72M-11.60%128.21M37.57%61.35M25.42%145.04M6.94%44.59M129.54%115.64M111.08%41.7M127.36%50.38M175.55%19.75M
Basic earnings per share 12.50%0.090.00%0.04-20.00%0.0833.33%0.0425.00%0.10.00%0.03166.67%0.08200.00%0.03200.00%0.03150.00%0.01
Diluted earnings per share
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--
Auditor PwC China (Special General Partnership)--PwC China (Special General Partnership)--Lixin Certified Public Accountants (Special General Partnership)--Lixin Certified Public Accountants (Special General Partnership)--Deloitte Touche Tohmatsu Certified Public Accountants (Special General Partnership)--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More